Showing results (1361-1370 of 3,400) with videos related to

Sort By:
Pageof 340
Eclinicalmedicine|March 3, 2023
Comparative onset of effect of biologics and small molecules in moderate-to-severe ulcerative colitis: a systematic review and network meta-analysisMohamed Attauabi, Emilie Kristine Dahl, Johan Burisch, et al.
Eclinicalmedicine|March 6, 2023
Mental health and psychosocial interventions integrating sexual and reproductive rights and health, and HIV care and prevention for adolescents and young people (10-24 years) in sub-Saharan Africa: a systematic scoping reviewOtsetswe Musindo, Sheharbano Jafry, Joseph Nyamiobo, et al.
Eclinicalmedicine|March 6, 2023
Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trialSophia Lengsfeld, Thilo Burkard, Andrea Meienberg, et al.
Eclinicalmedicine|March 6, 2023
Multiomic characterisation of the long-term sequelae of SARS survivors: a clinical observational studyKuan Li, Qian Wu, Hongjie Li, et al.
Eclinicalmedicine|March 27, 2023
Napabucasin plus nab-paclitaxel with gemcitabine versus nab-paclitaxel with gemcitabine in previously untreated metastatic pancreatic adenocarcinoma: an adaptive multicentre, randomised, open-label, phase 3, superiority trialTanios Bekaii-Saab, Takuji Okusaka, David Goldstein, et al.
Eclinicalmedicine|March 27, 2023
Corrigendum to "Treatment-related adverse events associated with HER2-Targeted antibody-drug conjugates in clinical trials: a systematic review and meta-analysis" [EClinicalMedicine 55 (2022) 101795]Zhiwen Fu, Jinmei Liu, Shijun Li, et al.
Eclinicalmedicine|March 27, 2023
Type of medication therapy for ADHD and stimulant misuse during adolescence: a cross-sectional multi-cohort national studyTy S Schepis, Kennedy S Werner, Olivia Figueroa, et al.
Eclinicalmedicine|March 27, 2023
Efficacy of inhaled hydrogen on neurological outcome following brain ischaemia during post-cardiac arrest care (HYBRID II): a multi-centre, randomised, double-blind, placebo-controlled trialTomoyoshi Tamura, Masaru Suzuki, Koichiro Homma, et al.
Eclinicalmedicine|January 30, 2023
A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of olanzapine plus triple antiemetic regimen for the prevention of multiday highly emetogenic chemotherapy-induced nausea and vomiting (OFFER study)Yuanyuan Zhao, Yunpeng Yang, Fangfang Gao, et al.
Eclinicalmedicine|February 23, 2023
Efficacy and safety of vixarelimab, a human monoclonal oncostatin M receptor β antibody, in moderate-to-severe prurigo nodularis: a randomised, double-blind, placebo-controlled, phase 2a studyHoward Sofen, Robert Bissonnette, Gil Yosipovitch, et al.
Pageof 340